Yoarly, Your Early Warning, by MDY Analytics
How it works

Two innovations, one device

Yoarly joins early warning from vitals with surrogate biomarkers, and delivers both as a warning the wearer and the clinician can act on.

The gap Yoarly closes

Three limits on how deterioration is seen today

Signals are read as snapshots

A measurement taken at intervals shows where the body is. Yoarly shows where it is heading and when it will get there.

Biomarkers arrive intermittently

The values that define clinical events exist only when a sample is taken and a test is run. Yoarly reports them continuously.

Monitoring stops at the door

Continuous monitoring belongs to the highest levels of care. Yoarly carries it to every person, wherever they are.

The two innovations

Two innovations, one output

Yoarly joins two innovations in one device. Each is complete on its own. Together they give a continuous forecast of the wearer's clinical state, expressed in the measures clinicians already act on.

The wearer signals, continuously Surrogate biomarkers every biomarker, no sample Early warning engine trajectory, zone, time The warning wearer and clinicians signals signals biomarker values, continuous biomarkers now what comes next
Figure 1The surrogates give the early warning engine the biomarkers that define the conditions it warns of. The warning carries both the present value and the forecast.
Innovation one

Early warning from vitals

A forecasting engine that turns a stream of measurements into a forward trajectory, a clinical zone, a time to threshold and an urgency level.

Innovation two

Surrogate biomarkers

A surrogate for every biomarker, so that each value is available continuously, from the signals the device already reads.

The device

The surrogates decide the sensing

Yoarly is built from the biomarkers outward. The surrogate for each biomarker specifies the signals it needs, and the sensing face of the device is built to deliver every one of them. Both innovations run on the device, on the wearer's own data.

WORN CONTINUOUSLY Display and warning condition, urgency, time to act Surrogates and forecast both innovations, on the device Sensing face every signal the surrogates need signals biomarkers, forecast Clinicians and wearer THE BODY
Figure 4The device in three layers. Signals rise from the sensing face, the surrogates and the forecast turn them into biomarkers and trajectories, and the warning reaches the wearer and their clinicians.
The warning

What Yoarly tells the wearer and the clinician

YOARLY LIVE THRESHOLD BIOMARKER RISING TIME TO ACT HOURS REVIEW ADVISED
Figure 5Illustration of the device face.
The condition
What is developing, named in clinical terms.
The evidence
The signals and biomarkers driving the warning, with their present values and their forecast course.
The urgency
A graded level, from continued watching to immediate action.
The time to act
How long remains before the threshold is reached.